Wake Up Call: Dechert Leads $1.48 Billion Rare Disease Drug Deal

Welcome to Bloomberg Law’s Wake Up Call, a daily rundown of the top news for lawyers, law firms, and in-house counsel.

• Dechert LLP is advising Italian biopharmaceutical company Chiesi Farmaceutici S.p.A. on Chiesi’s $1.48 billion deal to buy Dublin, Ireland-based drug developer Amryt Pharma Plc to get Amryt’s rare disease medicine portfolio. Cooley LLP and Gibson Dunn are advising Amryt Pharma on the transaction, which is expected to close in 2023’s first half, according to a statement. (Globe Newswire)
• Enterprise management software giant SAP SE poached Bayer AG group top lawyer Gabriel Harnier as the Waldorf, Germany-headquartered multinational’s ...